Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company’s product pipeline includes ALTO-100, which is in Phase 2b clinical trial for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback